top of page
LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities
London, 4 June 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil...
Jun 4, 2025
Our Chairman Tony de Fougerolles discusses innate immune rejuvenation
Chairman of LIfT BioSciences, to explore the concept of innate immune rejuvenation – a central pillar of our approach to overcoming...
May 28, 2025
LIfT BioSciences presents preclinical data on its first-in-class Immunomodulatory Alpha Neutrophils at American Society of Gene & Cell Therapy 28th Annual Meeting
showcasing its versatility in diseases beyond oncology London, 22 May 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly...
May 22, 2025
bottom of page